This inventor holds 1 USPTO granted patent. Top assignee: Cmic Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovations of Hirofumi Kasahara
Introduction
Hirofumi Kasahara is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid-containing complexes. His work focuses on enhancing the delivery and functionality of nucleic acids, which are essential for various biological processes.
Latest Patents
Hirofumi Kasahara holds a patent for a nucleic acid-containing complex. This innovative complex comprises a nucleic acid and a positively charged, water-insoluble biodegradable polymer. The unique properties of this complex allow for the sustained release of desired nucleic acids, especially DNA, to specific sites in the body. The complex can be effectively taken up by phagocytes, such as macrophages, facilitating targeted delivery and enabling the nucleic acid to function in a site-specific manner.
Career Highlights
Hirofumi Kasahara is associated with Cmic Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in gene therapy and other medical fields. His innovative approach to nucleic acid delivery systems positions him as a key figure in biotechnology.
Collaborations
Hirofumi has collaborated with notable colleagues, including Hidezo Mori and Yasuhiko Tabata. These partnerships have contributed to the advancement of their shared research goals and have fostered a collaborative environment for innovation.
Conclusion
Hirofumi Kasahara's contributions to the field of biotechnology, particularly through his patented nucleic acid-containing complex, highlight his role as an influential inventor. His work not only enhances the understanding of nucleic acid delivery but also paves the way for future advancements in medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile